Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]
Pulse Biosciences, Inc (PLSE)
Last pulse biosciences, inc earnings: 11/7 03:42 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.pulsebiosciences.com
Company Research
Source: Yahoo! Finance
For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Pulse Biosciences Inc ( NASDAQ:PLSE ) has made significant progress in advancing its three market development programs, particularly in soft tissue ablation and cardiac surgery systems. The company received FDA investigational device exemption approval for its impulse cardiac surgery system for atrial fibrillation, marking a significant regulatory milestone. The EPulse vibrance percutaneous electrode system for soft tissue ablation has shown strong product market fit, with over 200 patients treated and positive outcomes reported. Initial revenues were generated in Q3 2025, indicating early commercial traction for the company's products. The company is engaged in multiple clinical studies, including the precise BTN study and European feasibility studies, which are progressing well and expected to provide robust clinical evidence for their technologies. Nega
Show less
Read more
Impact Snapshot
Event Time:
PLSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLSE alerts
High impacting Pulse Biosciences, Inc news events
Weekly update
A roundup of the hottest topics
PLSE
News
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor ConferencesBusiness Wire
- Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial ResultsBusiness Wire
- Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF StudyBusiness Wire
PLSE
Earnings
- 11/5/25 - Beat
PLSE
Sec Filings
- 11/13/25 - Form 8-K
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- PLSE's page on the SEC website